Bessemer Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
Bessemer Group's HRMY Position: Q3 2026 in Review
Bessemer Group reduced its Harmony Biosciences (HRMY) stake by 4.7% in Q3 2026, selling an estimated $966 and leaving 505 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #1989.
Bessemer Group first reported a position in HRMY in Q1 2021 and has held it in 19 quarters since. 358 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.
- Bessemer Group held 505 shares of Harmony Biosciences worth $20K as of Q3 2026.
- Bessemer Group sold 25 Harmony Biosciences shares in Q3 2026, an estimated $966.
- Harmony Biosciences made up ﹤0.01% of Bessemer Group's portfolio in Q3 2026, its #1989 holding.
- Bessemer Group first reported a position in Harmony Biosciences in Q1 2021 and has held it in 19 quarters since.
- 358 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.
Based on Bessemer Group's 13F filing for Q3 2026, filed 9 Nov 2026.